Your session is about to expire
← Back to Search
3D-RT for Dementia
N/A
Waitlist Available
Led By Thomas Plocher, MS
Research Sponsored by Moai Technologies LLC
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Timeline
Screening 3 weeks
Treatment Varies
Follow Up will be administered at week 0 (prior to first therapy session) to establish a baseline. measures at week 8 (midpoint of therapy sessions), and week 16 (following last therapy session) will determine change from the baseline.
Awards & highlights
Summary
This trial will use 3D printing to create personalized objects for people with dementia, in order to improve their mood, quality of life, social interaction, and cognition.
Eligible Conditions
- Dementia
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ will be administered at week 0 (prior to first therapy session) to establish a baseline. measures at week 8 (midpoint of therapy sessions), and week 16 (following last therapy session) will determine change from the baseline.
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~will be administered at week 0 (prior to first therapy session) to establish a baseline. measures at week 8 (midpoint of therapy sessions), and week 16 (following last therapy session) will determine change from the baseline.
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Primary study objectives
Change in Cognitive stimulation/reminiscence
Secondary study objectives
Dementia
Change in Dementia severity-SLUMS
Change in Dementia severity-dependence on assistance
+3 moreOther study objectives
Functionality and usability of 3D printing mobile tools and paradigm for RT
Trial Design
3Treatment groups
Experimental Treatment
Active Control
Group I: 8 Weeks of 3D-RTExperimental Treatment1 Intervention
Participants will receive 8weeks of Reminiscence Therapy using 3D printed objects as stimuli and 8 weeks of RT using verbal stimuli.
Group II: 16 Weeks of 3D-RTExperimental Treatment1 Intervention
Participants will receive 16 weeks of Reminiscence Therapy using 3D printed objects as stimuli.
Group III: 16 Weeks of RT using Verbal StimuliActive Control1 Intervention
Participants will receive 16 weeks of RT using verbal stimuli to reminiscence.
Find a Location
Who is running the clinical trial?
University of Texas-ArlingtonUNKNOWN
4 Previous Clinical Trials
600 Total Patients Enrolled
Moai Technologies LLCLead Sponsor
1 Previous Clinical Trials
96 Total Patients Enrolled
The University of Texas at ArlingtonOTHER
44 Previous Clinical Trials
4,715 Total Patients Enrolled
2 Trials studying Dementia
533 Patients Enrolled for Dementia
Share this study with friends
Copy Link
Messenger